TETRAPHASE PHARMACEUTICALS INC (38) | Uncategorized (11)

Recent Contracts

Form of Support Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 24, 2020)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 24, 2020)
Form of Support Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 4, 2020)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 4, 2020)
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 29, 2020)
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 27, 2020)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on March 16, 2020)
Co-Promotion Agreement, dated March 15, 2020, by and between the Parent and the Company (Filed With SEC on March 16, 2020)
Description of Registrants Securities (Filed With SEC on March 12, 2020)
Payoff Letter, entered into as of August 30, 2019, by and among Tetraphase Pharmaceuticals, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders named... (Filed With SEC on August 30, 2019)
Offer letter, dated as of July 31, 2019, by and between the Registrant and Larry Edwards (Filed With SEC on August 8, 2019)